The successful knockdown of CA IX via siRNA mediation has shown to reduce primary tumor growth and proliferation in breast cancer models and also enhance effects of hexokinase inhibitors, promising compounds for treatment of liver cancer [112,113,115]. Here, CA9 is linked to neoplasm.